U.S. Markets closed

TG Therapeutics Breaks Out on Positive Umbralisib Data

TG Therapeutics Breaks Out on Positive Umbralisib Data

TG Therapeutics shares moved sharply higher after positive clinical data, but traders will be watching these key levels ahead.